An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breastcancer
Interventions: DRUG: Oraxol
Sponsor: Athenex, Inc.
Collaborators: PharmaEssentia